Condensed Interim Consolidated Statements of Changes in Equity (Deficit) - USD ($)	Common shares	Contributed surplus	Deficit	Non-controlling interest	Total
Balance at the beginning at Dec. 31, 2022	$ 114,120,362	$ 4,552,067	$ (175,007,144)	$ (2,777,127)	$ (59,111,842)
Balance at the beginning (in shares) at Dec. 31, 2022	29,436,545
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net comprehensive loss for the period			(10,591,310)	(68,826)	(10,660,136)
Share-based compensation (note 15)		62,948			62,948
Issuance of common shares (note 14)	$ 6,139,262				6,139,262
Issuance of common shares (note 14) (in shares)	11,363,635
Issuance of lender warrants		59,786			59,786
Acquisition of subsidiary non-controlling interest (note 23)			(118,052)	118,052
Balance at the end at Mar. 31, 2023	$ 120,259,624	4,674,801	(185,716,506)	(2,727,901)	(63,509,982)
Balance at the end (in shares) at Mar. 31, 2023	40,800,180
Balance at the beginning at Dec. 31, 2023	$ 120,741,061	5,397,700	(224,174,970)	(2,911,581)	(100,947,790)
Balance at the beginning (in shares) at Dec. 31, 2023	42,774,011
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net comprehensive loss for the period			(14,218,296)	(321,849)	(14,540,145)
Share-based compensation (note 15)		25,302			25,302
Issuance of common shares (note 14)	$ 495,649				$ 495,649
Issuance of common shares (note 14) (in shares)	2,828,249				2,828,249
Balance at the end at Mar. 31, 2024	$ 121,236,710	$ 5,423,002	$ (238,393,266)	$ (3,233,430)	$ (114,966,984)
Balance at the end (in shares) at Mar. 31, 2024	45,602,260